Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02906202
Brief Title: A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

First Submitted : August 19, 2016
First Submitted that Met QC Criteria : September 14, 2016
First Posted : September 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 23, 2020
Last Update Posted : December 24, 2020